Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.27
May. 13, 2025 15:23:00- Change 0.02 (1.6%)
- Volume 126,131
- Today's Open 1.22
- Previous Close 1.25
- Today's High 1.32
- Today's Low 1.22
- 52 Week High 4.3
- 52 Week Low 1.22